PRKAA1 and metabolic dysfunction-associated steatotic liver disease: The main pathways include PPAR signaling pathway, Adipocytokine signaling pathway, AMPK signaling pathway, Fatty acid metabolism, Non-alcoholic fatty liver disease (NAFLD).